Initial experience of enfortumab vedotin in a patient with metastatic urothelial carcinoma on hemodialysis: Two case reports.

Shintaro MoriTomohiro MatsuoHiroyuki HondaKyohei ArakiKensuke Mitsunari Kojiro OhbaYasushi MochizukiRyoichi Imamura

Published in: IJU case reports (2024)

The efficacy and safety of enfortumab vedotin in patients with metastatic urothelial carcinoma, and end-stage renal disease undergoing hemodialysis, were confirmed.

Keyphrases

end stage renal disease
peritoneal dialysis
chronic kidney disease
case report
hodgkin lymphoma
small cell lung cancer
squamous cell carcinoma